Holen Sie sich die Stockscreener-App
0.3371
0.03%
0.000100
Schlusskurs vom Vortag:
$0.337
Offen:
$0.34
24-Stunden-Volumen:
15,756
Relative Volume:
0.17
Marktkapitalisierung:
$4.86M
Einnahmen:
$389.00K
Nettoeinkommen (Verlust:
$-13.13M
KGV:
-0.3266
EPS:
-1.0323
Netto-Cashflow:
$-11.90M
1W Leistung:
+0.93%
1M Leistung:
-22.47%
6M Leistung:
-75.57%
1J Leistung:
-77.53%
1-Tages-Spanne:
$0.322
$0.34
1-Wochen-Bereich:
$0.305
$0.42
52-Wochen-Spanne:
$0.2711
$3.2324
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare CLGN vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.3371 | 4.86M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Collplant Biotechnologies Ltd (CLGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CollPlant Heads Toward Nasdaq Deadline With Stock at 40 Cents - Bez Kabli
CollPlant Biotechnologies (CLGN) Holds Near Support Amidst Modest Downside PressureBear Flag - newsline.com
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Sahm
CollPlant Biotechnologies Posts Wider Q1 Loss as It Explores Strategic Alternatives and Advances Regenerative Aesthetics Pipeline - The Globe and Mail
CollPlant Biotechnologies (CLGN) Hovers Near Support at $0.38 After Marginal DeclineTrend Continuation Trade - The Legal Advocate
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Benzinga
CollPlant (CLGN) Reports Q1 2026 Financials and Strategic Updates - GuruFocus
CollPlant Q1 revenue falls to $73K, initiates strategic review - grafa.com
Collplant Biotechnologies: No Definitive Timetable for Process >CLGN - Moomoo
Collplant Biotechnologies: Initiates Process to Evaluate Strategic Alternatives Aimed at Maximizing Shareholder Value >CLGN - Moomoo
Collplant Biotechnologies 1Q Loss $3.1M >CLGN - Moomoo
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies (CLGN) Slides 6.67% as Selling Pressure MountsHedge Fund Exposure - newsline.com
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Quantisnow
CLGN Q4 2025 Earnings: Miss on EPS as Pre-Revenue Biotech Advances PipelineViral Trade Signals - Newser
CLGN Q1'26 Earnings: revenue estimate is 460.00K USD - TradingView
TradingKey - TradingKey
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - MSN
CLGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Hugh M. Evans (CLGN) details CollPlant share, RSU and option holdings - Stock Titan
[EFFECT] CollPlant Biotechnologies Ltd SEC Filing - Stock Titan
CollPlant (CLGN) registers 3.296M shares for resale; warrants convertible into shares - Stock Titan
CollPlant (CLGN) Stock: Investment Potential Insight (Climbs) 2026-04-20Social Buzz Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Jasmine Seror Net Worth (2026) - GuruFocus
Avraham Havron Net Worth (2026) - GuruFocus
Elan Penn Net Worth (2026) - GuruFocus
Bowman Bagley Net Worth (2026) - GuruFocus
Bar Berta Abelis Net Worth (2026) - GuruFocus
Eran Rotem Net Worth (2026) - GuruFocus
Oren Fahimipoor Net Worth (2026) - GuruFocus
Philippe Bensimon Net Worth (2026) - GuruFocus
Yehiel Tal Net Worth (2026) - GuruFocus
CollPlant (NASDAQ: CLGN) registers 3.296M resale shares; warrants detail - Stock Titan
CLGN SEC FilingsCollplant Biotechnologies Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Momentum Shift: Can CollPlant Biotechnologies Ltd sustain earnings growthGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
CollPlant implementing cost-reduction and workforce optimization plan - TipRanks
CLGN Implements Major Cost-Cutting Measures for Future Growth - GuruFocus
CollPlant Ends AbbVie Partnership, Eyes New Opportunities Ahead - Intellectia AI
CollPlant Resets Strategy After AbbVie Ends Filler Deal, Slashes Workforce by 50% - TipRanks
CollPlant ends AbbVie deal, cuts workforce by 50% By Investing.com - Investing.com South Africa
CollPlant announces termination of development agreement with AbbVie - TipRanks
AbbVie ends CollPlant (NASDAQ: CLGN) filler pact as CollPlant slashes workforce 50% - Stock Titan
CollPlant Biotechnologies Ltd and Allergan Industrie SAS Terminate Development Agreement - marketscreener.com
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):